MedPath

Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

Completed
Conditions
COVID-19
Registration Number
NCT05328479
Lead Sponsor
Mahidol University
Brief Summary

The investigators assessed the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation.

Detailed Description

The investigators aimed to assess the effect of treatment for COVID and immunity of the volunteers who admitted to the home isolation. The investigators compared the population between the age groups 12-18 years, 18-45 years and over 45 years to monitor the symptoms of coronavirus patients treated in home isolation and long-term symptoms including factors related to the patient's recovery in the past, present, and future.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5181
Inclusion Criteria
  1. patient with infected with the novel coronavirus disease 2019 (COVID-19) who has been end of self-quarantine at Siriraj Hospital more than 21 days.
  2. Thai nationality, able to read and write Thai language
  3. able to use telephone and line to communicate
Exclusion Criteria
  1. people who received additional vaccination after leaving quarantine before the day of the immunization test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anti-SARS-CoV-2 RBD IgGBaseline

Anti-RBD IgG (BAU/mL)

Cycle threshold of the first PCR testBaseline

Cycle threshold (Ct)

Anti-SARS-CoV-2 NPBaseline

Anti-SARS-CoV-2 NP (PRNT50 titer)

Secondary Outcome Measures
NameTimeMethod
Type of vaccine injectionBaseline

Type of vaccine injection

Number of vaccine injectionBaseline

Number of vaccine injection

Trial Locations

Locations (1)

Faculty of Medicine Siriraj Hospital, Mahidol University

🇹🇭

Bangkok Noi, Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath